SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as community members rally behind its unique permissionless brand model, which integrates real-world product initiatives like energy drinks and spices with a grassroots, highly active culture. Supporters are actively encouraging new participants to engage with the project's ecosystem and 'build' alongside the community, viewing the current market sentiment as an opportunity to accumulate their holdings.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is currently trending as investors weigh strong AI-driven chip demand against heightened geopolitical supply chain risks involving the Strait of Hormuz and potential manufacturing energy constraints. The community is actively debating whether the stock's recent price action represents a classic "sell the news" opportunity or a strategic accumulation point given its indispensable role in the global AI hardware ecosystem.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors react to potential regulatory shifts regarding peptide compounding, fueling speculation of a short squeeze and long-term expansion. The community is actively debating the stock's growth trajectory and its potential for a major re-rate as sentiment remains split between bullish proponents of its personalized healthcare platform and skeptics questioning its valuation and long-term sustainability.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to a convergence of positive catalysts including a new DARPA contract and technical breakthroughs in photonic interconnects, which have fueled aggressive bullish sentiment. The community is actively debating the stock's potential for a massive short squeeze and long-term re-rating as a core infrastructure play, while many continue to monitor the interplay between high short interest and institutional accumulation.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently capturing investor interest as it shows signs of a recovery cycle and technical stabilization, fueled by active community speculation regarding potential corporate restructuring, layoffs, and M&A possibilities. Investors are closely monitoring the new leadership team's strategic vision, with many pointing to the company's aggressive share buybacks and low valuation multiples as strong indicators of long-term upside potential.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies has generated intense market attention following its recent debut, driven by its unique positioning as a pure-play photonic quantum computing company. The community is actively debating the stock's low-float momentum, high short interest, and speculative potential, while weighing the firm's strategic partnerships against concerns over its early-stage financial fundamentals.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant community attention as it navigates price fluctuations amidst broader crypto market volatility and geopolitical developments. Investors are actively debating potential breakout levels, with bullish sentiment driven by ecosystem growth, staking activity, and speculation regarding Solana's role in institutional adoption.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is trending as investors react to its strong fiscal Q1 earnings beat and robust guidance, which showcased significant revenue growth driven by sustained AI-related foundry and logic demand. While the stock initially saw volatility, community discussion remains highly focused on the company's long-term leadership in the wafer fabrication equipment cycle despite ongoing concerns regarding its revenue exposure to China.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is attracting intense attention as retail investors debate whether semiconductor strength reflects genuine AI demand or a bubble fueled by market manipulation and geopolitical tensions in the Middle East. While some traders are aggressively building short positions in anticipation of a cooling-off period for overextended chip stocks, others are wary of the aggressive leverage decay and the market's continued defiance of bearish sentiment.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is currently in the spotlight as investors evaluate the company's aggressive pivot toward internal combustion and hybrid production while managing significant write-downs from its electric vehicle segment. The community is actively debating the stock's valuation amid substantial share buyback programs and the potential impact of changing federal policy, while simultaneously monitoring its competitive standing against Ford and Tesla in a cooling EV market.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock...

Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TG Therapeutics, Inc. $TGTX Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 56.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The...

Nordea Investment Management AB Buys Shares of 79,696 TG Therapeutics, Inc. $TGTX

Nordea Investment Management AB purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 79,696 shares of the bi...

TG Therapeutics, Inc. $TGTX Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. increased its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 1,278.8% during the fourth quarter, according to its most recent filing with...

1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co.

Congress Asset Management Co. purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure...

TG Therapeutics Procures Additional $500 Mln Funding From Blue Owl Capital

(RTTNews) - TG Therapeutics, Inc. (TGTX), a commercial stage biopharmaceutical company, Thursday announced that it has obtained a new five-year, $750 million senior secured credit facility with funds...

Penn Capital Management Company LLC Grows Stock Position in TG Therapeutics, Inc. $TGTX

Penn Capital Management Company LLC boosted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 17.6% during the third quarter, according to the company in its most recent filing...

TG Therapeutics (NASDAQ:TGTX) Shares Up 7.9% - Here's What Happened

TG Therapeutics (NASDAQ:TGTX) Trading 7.9% Higher - Time to Buy...

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop

Key PointsACT Capital Management added 268,875 shares of TG Therapeutics in the fourth quarter...

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TGTX
TG Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TGTX News

TGTXTG Therapeutics Inc